Fig. 2From: The relevance of the non-invasive biomarkers lncRNA GAS5/miR-21 ceRNA regulatory network in the early identification of diabetes and diabetic nephropathyThe Changes in Expression of Serum lncRNA GAS5 and miR-21 in DM, DN, and N groups. (A, B) The average expression. aP<0.05 vs. the N group, bP<0.01 vs. the DM group. DN: diabetic nephropathy group; DM: diabetic group; N: normal control groupBack to article page